Expertise in
7
conditions

Dr. Rafael Lopez

Family Medicine
San Benito Medical Associates PLLC
351 N Sam Houston Blvd, 
San Benito, TX 
Offers Telehealth
Expertise in
7
conditions
San Benito Medical Associates PLLC
351 N Sam Houston Blvd, 
San Benito, TX 

Overview

Rafael Lopez is a primary care provider, practicing in Family Medicine in San Benito, Texas.

Dr. Lopez is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Meningitis, Acute Pain, and Encephalitis.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 26 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in TX

Hospital Affiliations

Vhs Harlingen Hospital Company LLC
Harlingen Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

San Benito Medical Associates PLLC
351 N Sam Houston Blvd, San Benito, TX 78586
Other Locations
Monzer H. Yazji MD & Associates PLLC
502 S Closner Blvd, Edinburg, TX 78539

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

26 Clinical Trials

A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Drug
Study Drugs: Palbociclib, Trastuzumab, Pertuzumab, Letrozole, Anastrozole, Exemestane, Fulvestrant
Study Phase: Phase 3
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
Enrollment Status: Active_not_recruiting
Publish Date: February 09, 2026
Intervention Type: Other
Study Phase: Not Applicable
Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection
Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection
Enrollment Status: Completed
Publish Date: February 09, 2026
Intervention Type: Diagnostic test
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2026
Intervention Type: Biological
Study Drug: Dostarlimab
Study Phase: Phase 1
A Phase II Single Arm Clinical Trial Assessing the Efficacy and Safety of BIntrafusp Alfa (M7824) in Previously Treated Advanced Malignant Pleural MESothelioma (BIMES)
A Phase II Single Arm Clinical Trial Assessing the Efficacy and Safety of BIntrafusp Alfa (M7824) in Previously Treated Advanced Malignant Pleural MESothelioma (BIMES)
Enrollment Status: Completed
Publish Date: December 23, 2025
Intervention Type: Drug
Study Drug: Bintrafusp alfa
Study Phase: Phase 2
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Drug
Study Drugs: Tucatinib, Trastuzumab, Fulvestrant
Study Phase: Phase 2
A Phase II Open Label Study of Atezolizumab in Combination With Bevacizumab as First Line Treatment for Locally Advanced or Metastasic High-intermediate Tumor Mutation Burden Selected Non-squamous Non-small Cell Lung Cancer Patients.
A Phase II Open Label Study of Atezolizumab in Combination With Bevacizumab as First Line Treatment for Locally Advanced or Metastasic High-intermediate Tumor Mutation Burden Selected Non-squamous Non-small Cell Lung Cancer Patients.
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug
Study Drug: Atezolizumab+Bevacizumab
Study Phase: Phase 2
Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment
Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Nivolumab Plus Ipilimumab Plus Two Cycles of Platinum-based Chemotherapy as First Line Treatment for Stage IV/Recurrent Non-small Cell Lung Cancer (NSCLC) Patients With Synchronous Brain Metastases
Nivolumab Plus Ipilimumab Plus Two Cycles of Platinum-based Chemotherapy as First Line Treatment for Stage IV/Recurrent Non-small Cell Lung Cancer (NSCLC) Patients With Synchronous Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drugs: Ipilimumab, Nivolumab, Carboplatin, Cisplatin, Paclitaxel, Pemetrexed
Study Phase: Phase 2
View 9 Less Clinical Trials

4 Total Publications

CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis.
CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis.
Journal: mBio
Published: July 27, 2021
Similar Doctors
Expertise in
41
conditions
Dr. Juan Garcia
Family Medicine
Expertise in
41
conditions
Dr. Juan Garcia
Family Medicine

Office

2211 S 77 Sunshine Strip Ste 304, 
Harlingen, TX 
 (5.0 miles away)
956-399-1641
Languages Spoken:
English
See accepted insurances

Juan Garcia is a primary care provider, practicing in Family Medicine in Harlingen, Texas. Dr. Garcia is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Vitamin D Deficiency, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Glucocorticoid-Remediable Aldosteronism.

Expertise in
69
conditions
Dr. Enrique Griego
Family Medicine
Expertise in
69
conditions
Dr. Enrique Griego
Family Medicine

Enrique Griego M.D.P.A.

1900 S Jackson Rd Ste 9, 
Mcallen, TX 
 (33.9 miles away)
956-687-6682
Languages Spoken:
English
See accepted insurances

Enrique Griego is a primary care provider, practicing in Family Medicine in Mcallen, Texas. Dr. Griego is highly rated in 69 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Osteomyelitis in Children, Vitamin D Deficiency, and High Cholesterol.

Expertise in
11
conditions
Dr. Rafael Rafols
Family Medicine
Expertise in
11
conditions
Dr. Rafael Rafols
Family Medicine

DHR Health Wound Care Center

5509 Doctors Dr, 
Edinburg, TX 
 (31.5 miles away)
956-362-5525
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rafael Rafols is a primary care provider, practicing in Family Medicine in Edinburg, Texas. Dr. Rafols is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Peptic Ulcer, Necrosis, Cellulitis, Osteomyelitis, and Myringotomy.

Frequently Asked Questions about Dr. Rafael Lopez

How do I make an appointment with Dr. Rafael Lopez?

You can book an appointment with Dr. Rafael Lopez by calling their office at 956-399-2443. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rafael Lopez a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rafael Lopez is classified as an Advanced expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rafael Lopez specialize in?

While Dr. Rafael Lopez is a Family Medicine, they have specific expertise in Type 2 Diabetes (T2D), Meningitis, and Acute Pain. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Rafael Lopez participate in research or clinical trials?

Yes. Dr. Rafael Lopez has published 4 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Dr. Rafael Lopez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rafael Lopez accept my insurance?

Dr. Rafael Lopez accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 956-399-2443 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lopez's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 70 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile